Heat Biologics, Inc.
HTBX
Price:
$2.38
Market Cap:
$61.07M
Heat Biologics, Inc., an integrated biopharmaceutical company, engages in the development of immune therapies and vaccines. The company's therapies are used to modulate the immune system against various diseases, including cancer and infectious diseases. Its gp96 platform, including ImPACT, an allogenic cell-based, T-cell-stimulating platform that functions as an immune activator to stimulate and expand T-cells; and ComPACT, which delivers antigen driven T-cell activation and specific co-stimulation in a single product. The company develops HS-110, which has completed enrollment in a Phase II clinical trial to treat patients with advanced non-small cell lung cancer; and HS-130 that is in Pha...[Read more]
Industry
Biotechnology
IPO Date
2013-07-24
Stock Exchange
AMEX
Ticker
HTBX
PE Ratio
[-2.07]
ROE
[-1764.70%]
Current Ratio
[0.09]
Dividend Yield
[0%]
Enterprise Value
[20.56T]
Dividend History
The ROE as of November 2025 (TTM) for Heat Biologics, Inc. (HTBX) is -1764.70%
According to Heat Biologics, Inc.’s latest financial reports and current stock price. The company's current ROE is -1764.70%. This represents a change of -3005.09% compared to the average of 60.74% of the last 4 quarters.
Heat Biologics, Inc. (HTBX) Historical ROE (quarterly & annually)
How has HTBX ROE performed in the past?
The mean historical ROE of Heat Biologics, Inc. over the last ten years is -102.97%. The current -1764.70% ROE has changed 1.61% with respect to the historical average. Over the past ten years (40 quarters), HTBX's ROE was at its highest in in the March 2025 quarter at 783.77%. The ROE was at its lowest in in the December 2024 quarter at -520.79%.
Average
-102.97%
Median
-76.09%
Minimum
-500.99%
Maximum
168.20%
Heat Biologics, Inc. (HTBX) ROE by Quarter and Year
Discovering the peaks and valleys of Heat Biologics, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 399.78%
Maximum Annual ROE = 168.20%
Minimum Annual Increase = -123.55%
Minimum Annual ROE = -500.99%
| Year | ROE | Change |
|---|---|---|
| 2021 | -31.60% | 41.00% |
| 2020 | -22.41% | -84.81% |
| 2019 | -147.50% | 183.95% |
| 2018 | -51.94% | -67.67% |
| 2017 | -160.66% | 12.39% |
| 2016 | -142.94% | -71.47% |
| 2015 | -500.99% | 399.78% |
| 2014 | -100.24% | 153.06% |
| 2013 | -39.61% | -123.55% |
| 2012 | 168.20% | -75.32% |
Heat Biologics, Inc. (HTBX) Average ROE
How has HTBX ROE performed in the past?
The current ROE of Heat Biologics, Inc. (HTBX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-67.17%
5-year avg
-82.82%
10-year avg
-102.97%
Heat Biologics, Inc. (HTBX) ROE vs. Peers
How is HTBX’s ROE compared to its peers?
Heat Biologics, Inc.’s ROE is greater than Achilles Therapeutics plc (-32.91%), less than Reneo Pharmaceuticals, Inc. (38.83%), greater than TCR2 Therapeutics Inc. (-71.90%), greater than Sigilon Therapeutics, Inc. (-74.73%), greater than Surface Oncology, Inc. (-61.52%), greater than Kronos Bio, Inc. (-64.22%), greater than Quince Therapeutics, Inc. (-186.08%), greater than MindWalk Holdings Corp. (-114.30%), greater than AlloVir, Inc. (-76.00%), greater than The Valens Company Inc. (-25.35%),
| Company | ROE | Market cap |
|---|---|---|
| -32.91% | $60.83M | |
| 38.83% | $60.84M | |
| -71.90% | $58.11M | |
| -74.73% | $56.22M | |
| -61.52% | $65.08M | |
| -64.22% | $53.65M | |
| -186.08% | $217.16M | |
| -114.30% | $93.00M | |
| -76.00% | $49.48M | |
| -25.35% | $61.46M |
Build a custom stock screener for Heat Biologics, Inc. (HTBX) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Heat Biologics, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
Heat Biologics, Inc. (HTBX) and other stocks custom spreadsheet templates
The easiest way to analyze a company like Heat Biologics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is Heat Biologics, Inc.'s ROE?
How is the ROE calculated for Heat Biologics, Inc. (HTBX)?
What is the highest ROE for Heat Biologics, Inc. (HTBX)?
What is the 3-year average ROE for Heat Biologics, Inc. (HTBX)?
What is the 5-year average ROE for Heat Biologics, Inc. (HTBX)?
How does the current ROE for Heat Biologics, Inc. (HTBX) compare to its historical average?